AIDS Treatment News logo      

July 23, 2009

Boosted and unboosted atazanavir maintain viral suppression equally well

"Unboosted atazanavir (Reyataz) taken once-daily as part of a combination antiretroviral regimen can keep viral load undetectable in patients who discontinue ritonavir, researchers reported on Wednesday at the Fifth International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention in Cape Town, South Africa.

In the ARIES trial, more than 500 treatment-naive HIV patients started a regimen of boosted atazanavir/ritonavir (300/100 mg) taken once daily plus the fixed-dose abacavir/3TC combination pill (Kivexa). "

Read more in Aidsmap, July 23, 2009.